CVC  M Ventures

http://www.m-ventures.com





     Office Locations:

Gustav Mahlerplein
102 Toyo lto Building, 20th Floor
Amsterdam, 1082 MA
The Netherlands

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. The firm's mandate is to invest in innovative technologies and products with the potential to significantly impact Merck KGaA, Darmstadt, Germany's core business areas. From headquarters in Amsterdam and offices in the U.S. and Israel, M Ventures invests globally in transformational ideas driven by great entrepreneurs. The firm takes an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early stage investing and company creation including the creation of spin-offs to leverage Merck KGaA, Darmstadt, Germany's science and technology base.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dr. Stefan Oschmann CEO
    Jasper Bos Vice President
    Laura Braeuninger-Weimer Head of Venture Operations
    Roel Bulthuis Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      05/09/2018


      Akili Interactive Labs


      MA


      $55,000,000


      Series C


      11/27/2017


      Biolinq


      CA


      $10,000,000


      Series A


      06/29/2017


      Indi Molecular


      CA


      $11,500,000


      Series A


     

    Portfolio companies include:


      Akili Interactive Labs
        web link


      Biolinq
        web link


      Indi Molecular
        web link


      MediSafe
        web link


     

    Recent News: